Novo Nordisk Mostly Escapes Insulin Pen Contamination Suit

By Jonathan Capriel · February 11, 2025, 9:14 PM EST

Novo Nordisk has, for now, beaten much of a Connecticut-based hospital's federal lawsuit seeking to hold it financially responsible for the $1 million settlement the hospital paid to patients potentially exposed...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

Griffin Health Services Corporation et al v. Novo Nordisk Inc. et al

Case Number

Court

Connecticut

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Date Filed

June 13, 2024

Recent Articles By Jonathan

February 20, 2025
Nootropics Co. Can't Push Nurse's Suit To Arbitration
December 12, 2024
Judge Troubled By Conduct Of Pot Farmer And State Officials
December 11, 2024
Pot Farmer Opposes Sanctions In Suit Over Mistaken Raid
November 26, 2024
Officials Must Face Claims From Pot Farm Raid, Grower Says
November 25, 2024
5th Circ. Upholds Miss. Ban On Medical Pot Ads
November 14, 2024
NY Nursing Homes Ink $45M Deal To End AG's Fraud Suit
October 16, 2024
SEC To Settle Claims CBD Exec Took $13M From Hospital
October 15, 2024
Conn. Medical Group Hit With $30M Verdict In C-Section Suit
September 04, 2024
Albertsons Denied Texas Court Remand In Opioid MDL
May 29, 2024
5th Circ. Sends Hain Toxic Baby Food Suit To State Court